Pacer Advisors
VNDA icon

Pacer Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Pacer Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-313,362
Closed -$2.32M – 2385
2022
Q4 		$2.32M Buy
313,362
+82,066
+35% +$799K 0.01% 542
2022
Q3 		$2.29M Sell
231,296
-24,478
-10% -$258K 0.02% 424
2022
Q2 		$2.79M Buy
255,774
+41,987
+20% +$435K 0.02% 420
2022
Q1 		$2.42M Buy
213,787
+107,664
+101% +$1.42M 0.02% 557
2021
Q4 		$1.67M Buy
106,123
+35,511
+50% +$619K 0.02% 902
2021
Q3 		$1.21M Buy
70,612
+13,677
+24% +$240K 0.02% 807
2021
Q2 		$1.23M Buy
56,935
+23,812
+72% +$426K 0.02% 774
2021
Q1 		$498K Buy
33,123
+21,239
+179% +$344K 0.01% 1064
2020
Q4 		$156K Buy
11,884
+1,067
+10% +$12.8K ﹤0.01% 1276
2020
Q3 		$104K Buy
10,817
+5,641
+109% +$60.3K ﹤0.01% 1244
2020
Q2 		$59K Sell
5,176
-60
-1% -$679 ﹤0.01% 857
2020
Q1 		$60K Sell
5,236
-5,460
-51% -$67.7K ﹤0.01% 535
2019
Q4 		$176K Sell
10,696
-5,429
-34% -$82.1K 0.01% 1120
2019
Q3 		$214K Buy
16,125
+6,316
+64% +$88K ﹤0.01% 1086
2019
Q2 		$138K Buy
+9,809
New +$156K ﹤0.01% 1083
2018
Q4 		– Sell
-3,823
Closed -$88K – 1031
2018
Q3 		$88K Buy
+3,823
New +$78.1K ﹤0.01% 1104
2018
Q1 		– Sell
-1,125
Closed -$17K – 1132
2017
Q4 		$17K Buy
+1,125
New +$16.7K ﹤0.01% 1110

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pacer Advisors's VNDA Position: Q1 2023 in Review

Pacer Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q1 2023, closing a stake of 313,362 shares — an estimated $2.32M sold.

Pacer Advisors first reported a position in VNDA in Q4 2017 and held it in 17 quarters. The position peaked at $2.79M in Q2 2022. 177 funds tracked by Wall St. Rank hold VNDA as of Q1 2023.

  • Pacer Advisors reported no remaining Vanda Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Pacer Advisors sold 313,362 Vanda Pharmaceuticals shares in Q1 2023, an estimated $2.32M.
  • Pacer Advisors first reported a position in Vanda Pharmaceuticals in Q4 2017 and held it in 17 quarters.
  • Pacer Advisors's Vanda Pharmaceuticals position peaked at $2.79M in Q2 2022.
  • 177 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2023.

Based on Pacer Advisors's 13F filing for Q1 2023, filed 2 May 2023.